Defining a minimally clinically identifiable difference in the minimum level at which tinnitus is completely masked

ISRCTN ISRCTN91448124
DOI https://doi.org/10.1186/ISRCTN91448124
Secondary identifying numbers NRF - 2023R1A2C1002929
Submission date
30/06/2023
Registration date
03/07/2023
Last edited
08/07/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Ear, Nose and Throat
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Minimum masking level (MML) is a method of measuring the minimum intensity of a masking sound to mask tinnitus. If the MML decreases after tinnitus treatment, the patient's perception of tinnitus decreases. The MML has been suggested to be an important indicator of changes in neural activity that can detect tinnitus signals; however, no evidence exists showing that the MML is a reliable way to measure changes in tinnitus loudness. Therefore, once the minimally clinically identifiable difference (MCID) of a measurement method using the MML is determined, it can be a valid and effective measure of tinnitus loudness reduction in patients with chronic tinnitus. This study aimed to develop a reliable measure of loudness changes in tinnitus using the MCID of the MML.

Who can participate?
People aged 19 to 75 years with chronic subjective tinnitus

What does the study involve?
Participants will be allocated to receive treatment for 3 months and will complete a number of tests and questionnaires 3 months before, during, and after treatment. Participants will receive tinnitus counseling and sound therapy. The counseling will be educational, providing information about tinnitus and how to deal with it, and will consist of six to twelve sessions lasting about 2 weeks. Sound therapy will be provided for 2 hours a day for 3 months using a self-developed sound therapy application and headphones. The duration of the daily sound therapy will be recorded using the application's data-logging system.

What are the possible benefits and risks of participating?
Some participants may experience a reduction in the loudness of their tinnitus or an improvement in tinnitus. There are no risks expected.

Where is the study run from?
Hallym University (South Korea)

When is the study starting, and how long is it expected to run for?
June 2023 to June 2024

Who is funding the study?
National Research Foundation of Korea (NRF) (South Korea)

Who is the main contact?
Prof. In-Ki Jin, inkijin@hallym.ac.kr

Contact information

Mr Tae-Jun Jin
Public

125, Sakju-ro
Chuncheon-si
24253
Korea, South

ORCiD logoORCID ID 0009-0009-2604-569X
Phone +82 (0)10 7387 2711
Email inkijin@hallym.ac.kr

Study information

Study designRepeated measures within-subject study
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Home, Laboratory
Study typeOther, Treatment
Participant information sheet https://www.nrf.re.kr/index
Scientific titleQuantifying tinnitus perception improvement: deriving the minimal clinically important difference of the minimum masking level
Study objectivesThe minimum masking level (MML) can be a valid and effective way to measure tinnitus loudness reduction in patients with chronic tinnitus if the minimally clinically identifiable difference (MCID) is determined.
Ethics approval(s)

Approved 08/06/2023, The Institutional Review Board of Hallym University (Hallym University 1 Hallymdaehak-gil, Chuncheon, 24252, Korea, South; No telephone number provided; irb@hallym.ac.kr), ref: HIRB-2023-033

Health condition(s) or problem(s) studiedChronic subjective tinnitus
InterventionParticipants will receive tinnitus counseling and sound therapy. The counseling will be educational, providing information about tinnitus and how to deal with it, and will consist of six to twelve sessions lasting about 2 weeks. Sound therapy will be provided for 2 h a day for 3 months using a self-developed sound therapy application and headphones. The duration of the daily sound therapy will be recorded using the application's data-logging system.
Intervention typeBehavioural
Primary outcome measureCurrent primary outcome measures as of 11/06/2024:
1. Tinnitus loudness is measured using the Clinical Global Impression (CGI, 5 points) at 3 months
2. Loudness of tinnitus is measured using the minimum masking level (MML, decibels) at baseline and 3 months

Previous primary outcome measures:
1. Tinnitus loudness is measured using the Clinical Global Impression (CGI, 5 points) at 1.5 and 3 months
2. Loudness of tinnitus is measured using the minimum masking level (MML, decibels) at 1.5 and 3 months
Secondary outcome measuresCurrent secondary outcome measures as of 11/06/2024:
1. Hearing threshold is measured using the puretone audiometry (decibels) at baseline and 3 months
2. Tinnitus frequency and loudness are measured using tinnitogram (Herz and decibels) at baseline and 3 months
3. Quality of life impairment due to tinnitus is measured by the Korean version of the Tinnitus Primary Function Questionnaire (K-TPFQ, 100 points) at baseline and 3 months

Previous secondary outcome measures:
1. Hearing threshold is measured using the puretone audiometry (decibels) at baseline, 1.5 months, and 3 months
2. Tinnitus frequency and loudness are measured using tinnitogram (Herz and decibels) at baseline, 1.5 months, and 3 months
3. Loudness and annoyance of tinnitus are measured using the visual analog scale (100 points) at baseline, 1.5 months, and 3 months
4. Quality of life impairment due to tinnitus is measured by the Korean version of the Tinnitus Primary Function Questionnaire (K-TPFQ, 100 points) at baseline, 1.5 months, and 3 months
Overall study start date07/06/2023
Completion date06/06/2024

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit19 Years
Upper age limit75 Years
SexBoth
Target number of participants72
Total final enrolment74
Key inclusion criteriaCurrent inclusion criteria as of 11/06/2024:
1. Subjective chronic tinnitus
2. Participants complaining of discomfort and irritation due to tinnitus
3. Pure-tone hearing thresholds of <40-dB hearing level at 0.5, 1, and 2 kHz
4. Average score of the Korean version of the Tinnitus Primary Function Questionnaire (K-TPFQ) >30 points
5. Participants willing to undergo pure tone audiometry, tinnitogram, minimum masking Level (MML), the Korean version of the Tinnitus Primary Function Questionnaire (K-TPFQ), and Clinical Global Impression (CGI)

Previous inclusion criteria:
1. Subjective chronic tinnitus
2. Participants complaining of discomfort and irritation due to tinnitus
3. Pure-tone hearing thresholds of <40-dB hearing level at 0.5, 1, and 2 kHz
4. Average score of the Korean version of the Tinnitus Primary Function Questionnaire (K-TPFQ) >30 points
5. Participants willing to undergo pure tone audiometry, tinnitogram, minimum masking Level (MML), visual analog scale (VAS), the Korean version of the Tinnitus Primary Function Questionnaire (K-TPFQ), and Clinical Global Impression (CGI)
Key exclusion criteria1. Participants experiencing a scientific disease (acoustic tumor, otitis media, hyperacusis, etc) or mental disorder
2. Participants currently undergoing litigation associated with tinnitus
Date of first enrolment05/07/2023
Date of final enrolment11/11/2023

Locations

Countries of recruitment

  • Korea, South

Study participating centre

Hallym University
1 Hallimdaehak-gil
Chuncheon
24252
Korea, South

Sponsor information

National Research Foundation of Korea
Government

201, Gajeong-Ro, Yuseong-Gu
Daejeon
34113
Korea, South

Phone +82 (0)42 869 6114
Email basicresearch@nrf.re.kr
Website https://www.nrf.re.eng/index
ROR logo "ROR" https://ror.org/013aysd81

Funders

Funder type

Government

National Research Foundation of Korea
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
한국연구재단이 창의적 연구와, National Research Foundation (South Korea), NRF
Location
Korea, South

Results and Publications

Intention to publish date15/10/2024
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planResearch using these data will be published in a peer-reviewed hearing journal
IPD sharing planThe datasets generated and/or analyzed in the current study are available upon request from In-Ki Jin (inkijin@hallym.ac.kr)
The type of data that will be shared: Excel spreadsheet
Dates of availability: 01/03/2024
Whether consent from participants was required and obtained: Yes
Comments on data anonymization: The data will be anonymized.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 04/02/2025 08/07/2025 Yes No

Editorial Notes

08/07/2025: Publication reference added.
11/06/2024: The following changes were made to the study record:
1. The scientific title was changed from 'Development of predicting tinnitus loudness change based on minimum masking level measurement method and identification of minimally clinically identifiable difference' to 'Quantifying tinnitus perception improvement: deriving the minimal clinically important difference of the minimum masking level'.
2. The primary and secondary outcome measures and inclusion criteria were updated.
3. The target number of participants was changed from 46 to 72.
4. The total final enrolment number was changed from 40 to 74.
5. The recruitment start date was changed from 01/08/2023 to 05/07/2023.
6. The recruitment end date was changed from 31/10/2023 to 11/11/2023.
10/10/2023: The total final enrolment was added.
30/06/2023: Study's existence confirmed by the Institutional Review Board of Hallym University.